Impact of Priming the Infusion System on the Performance of Target-controlled Infusion of Remifentanil
NCT01477905
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Intravenous Drug Usage
Interventions
DEVICE:
Remi50 with prime
DEVICE:
Remi20 with prime
Sponsor
Ajou University School of Medicine